Postoperative Nausea and Vomiting Clinical Trial
Official title:
Intraoperative Intravenous Dextrose Administration and the Incidence of Nausea and Vomiting After the Gynecologic Laparoscopic Surgery A Randomized Double-Blinded Controlled Study
The investigators tested the hypothesis that administration of intravenous dextrose as a
maintenance fluid in gynecologic laparoscopic surgery would reduce the incidence and
severity of postoperative nausea and vomiting (PONV) compared with normal saline solution in
the same dose.
A prospective randomized double blinded controlled study was conducted. Eighty six
participants were randomized to dextrose solution (n= 42) or normal saline solution (n= 44).
The Bellville postoperative nausea and vomiting scores were recorded until 24 hours after
surgery.
Postoperative nausea and vomiting (PONV) is a major complication in laparoscopic gynecologic
surgery. There are limited data and conflicting results from previous studies related to the
types of intravenous fluid and a reduction in PONV. The incidence of nausea is slightly
greater than the incidence of vomiting (50% vs. 30%). General anesthesia increased the
likelihood of PONV 11 times compared with other types of anesthesia. Laparoscopic surgery
can further increase the incidence of PONV to 80%.Identified risk factors of PONV included
female, history of motion sickness, nonsmoking, younger age, general anesthesia, use of
volatile anesthetics and nitrous oxide, opioids, duration of anesthesia, and types of
surgery (cholecystectomy, laparoscopic, gynecological). Adequate intravenous fluid hydration
is another effective strategy for reducing the baseline risk for PONV (Evidence A2).
Previous studies showed that there was no difference in efficacy between crystalloids and
colloids when similar volumes were used in surgeries associated with minimal fluid shifts.
While liberal intravenous fluid administration, such as 30 ml/ kg of sodium lactate
solution, reduced the incidence of PONV after gynecologic laparoscopy compared to another
group receiving 10 ml/kg of sodium lactate solution, this strategy did not reduce the PONV
in other surgical procedures such as thyroidectomy. Among crystalloid solutions, results
from previous studies were conflicting regarding the benefit of intravenous dextrose
administration to reducing the PONV. Hypovolemia with and without hypoglycemia after
overnight fasting were believed to exacerbate PONV.
The investigators hypothesized that intraoperative infusion of dextrose solution could
reduce the incidence and severity of PONV. The investigators proposed to determine the
relationship between types of fluid administration and antiemetic requirement and serum
glucose in paricipants scheduled for the gynecologic laparoscopy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04466046 -
The Effect on Anxiolytics With Type of Antiemetic Agents on Postoperative Nausea and Vomiting in High Risk Patients
|
||
Recruiting |
NCT04069806 -
Preoperative Oral Carbohydrate for Nausea and Vomiting Prevention During Cesarian Section
|
N/A | |
Completed |
NCT04043247 -
Transcutaneous Electrical Acupoint Stimulation for Prevention of Postoperative Nausea and Vomiting
|
N/A | |
Terminated |
NCT01975727 -
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
|
Phase 2 | |
Completed |
NCT03662672 -
Rib Raising for Post-operative Ileus
|
N/A | |
Completed |
NCT00090155 -
2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
|
Phase 3 | |
Recruiting |
NCT05375721 -
Prevention of PONV With Traditional Chinese Medicine
|
N/A | |
Completed |
NCT02480088 -
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
|
Phase 4 | |
Recruiting |
NCT06137027 -
Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
|
Early Phase 1 | |
Not yet recruiting |
NCT05529004 -
A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy
|
Phase 2 | |
Completed |
NCT02944942 -
Risk Factors for Postoperative Nausea/Vomiting
|
N/A | |
Recruiting |
NCT02571153 -
Low Doses of Ketamine and Postoperative Quality of Recovery
|
Phase 4 | |
Completed |
NCT02550795 -
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
|
N/A | |
Completed |
NCT02449291 -
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
|
Phase 3 | |
Recruiting |
NCT01442012 -
Utility of Acupuncture in the Treatment of Postoperative Nausea and Vomiting in Ambulatory Surgery
|
N/A | |
Completed |
NCT01478165 -
Comparison of TIVA (Total Intravenous Anesthesia) and TIVA Plus Palonosetron in Preventing Postoperative Nausea and Vomiting
|
N/A | |
Unknown status |
NCT01268748 -
Single Port Versus Four Ports Laparoscopic Cholecystectomy and Early Postoperative Pain
|
N/A | |
Completed |
NCT02143531 -
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
|
Phase 4 | |
Completed |
NCT00734929 -
Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy
|
Phase 4 | |
Withdrawn |
NCT00151099 -
Safety of Preoperative Oral Administration of a High Caloric Drink With Protein
|
Phase 4 |